| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/22/1998 | EP0853617A1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 07/22/1998 | EP0853616A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853479A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/22/1998 | EP0853475A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 07/22/1998 | EP0748312B1 Bicyclic carbamates as leukotriene d4 antagonists |
| 07/22/1998 | EP0725775B1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/22/1998 | EP0677042B1 Selective ligands of 5ht1d-5ht1b receptors derived from indole-piperazine useful as medicaments |
| 07/22/1998 | EP0643767B1 Osteogenic peptides |
| 07/22/1998 | EP0462964B1 Topical compositions containing aliphatic amines for the treatment of skin diseases |
| 07/22/1998 | EP0444157B1 Collagen-polymer conjugates |
| 07/22/1998 | CN1188414A Novel formulation for peptide release |
| 07/22/1998 | CN1188412A Means for treating radiation injuries |
| 07/22/1998 | CN1188111A 4-hydroxy-piperidine derivatives |
| 07/22/1998 | CN1188002A Drug for curing nephrosis and its preparing method |
| 07/22/1998 | CN1187993A Drug for promoting puerperal physiological recovery and curing postpartum disease |
| 07/22/1998 | CA2227112A1 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/21/1998 | US5783682 Oligonucleotide mimics having nitrogen-containing linkages |
| 07/21/1998 | US5783602 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 07/21/1998 | US5783594 Administering to treat glioma, colon cancer and immunological disordaers |
| 07/21/1998 | US5783590 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz CD!indoles |
| 07/21/1998 | US5783589 2-saccharinylmethyl aryl and arloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/21/1998 | US5783587 Psychological and brain disorders |
| 07/21/1998 | US5783574 Imidazolylakyl derivatives of imidazo 5,1-c! 1,4!benzoxazin-1-one process for their preparation |
| 07/21/1998 | US5783572 Treatment of neurodegenerative disorders |
| 07/21/1998 | US5783569 An immunostimulant which does not cause fever or inflammation, derived from yeast, wound healing |
| 07/21/1998 | US5783558 Treatment of bone disorders; calcium regulation |
| 07/21/1998 | US5783186 Antibody-induced apoptosis |
| 07/21/1998 | CA1339964C Substituted adenine derivatives useful as therapeutic agents |
| 07/17/1998 | CA2227132A1 Pharmaceutical compounds |
| 07/17/1998 | CA2227046A1 Peptides for use in wound treatment |
| 07/16/1998 | WO1998030696A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030693A2 Tumor necrosis factor receptor 5 |
| 07/16/1998 | WO1998030590A2 Analogs of parathyroid hormone |
| 07/16/1998 | WO1998030589A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030584A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030582A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030558A2 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 07/16/1998 | WO1998030556A1 Novel benzofuranone derivatives and process for producing the same |
| 07/16/1998 | WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION |
| 07/16/1998 | WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | WO1998030241A1 Methods of therapeutic administration of anti-cd40l compounds |
| 07/16/1998 | WO1998030234A1 Compositions for osteogenesis and chondrogenesis |
| 07/16/1998 | WO1998030224A1 Inhibitor of immunoglobulin e antibody production |
| 07/16/1998 | WO1998030223A1 Cytokine related treatments of disease |
| 07/16/1998 | WO1998030220A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | WO1998024463A3 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 07/16/1998 | WO1998021222A3 1-galactose derivatives |
| 07/16/1998 | WO1998019998A3 N-substituted 2-cyanopyrrolidines |
| 07/16/1998 | WO1998019697A3 Novel pharmaceutical compositions |
| 07/16/1998 | WO1997048672A3 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
| 07/16/1998 | CA2277223A1 Methods of therapeutic administration of anti-cd40l compounds |
| 07/16/1998 | CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | CA2276088A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2276085A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2276063A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2272941A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852950A1 Nitrogen monoxide production suppressor |
| 07/15/1998 | EP0852587A2 Synthetic peptides that inhibit il-6 activity |
| 07/15/1998 | EP0852499A1 Therapeutic azide compounds |
| 07/15/1998 | EP0852495A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/15/1998 | EP0852494A2 Peripherally active anti-hyperalgesic opiates |
| 07/15/1998 | EP0852491A1 Use of heparinases to decrease inflammatory responses |
| 07/15/1998 | EP0852463A1 Myogenic differentiation of human mesenchymal stem cells |
| 07/15/1998 | EP0646119B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 07/15/1998 | EP0528926B1 Soluble peptide analogues containing binding sites |
| 07/15/1998 | CN1187821A Rapamycin derivatives |
| 07/15/1998 | CN1187769A Lactacystin analogs |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187369A Nitrogen oxide generation inhibitor |
| 07/15/1998 | CN1039126C Tachiquinine antagonist tricyclic compounds and pharmaceutical compositions containing such compounds |
| 07/14/1998 | US5780667 Phosphodiesterase-4 and tumor necrosis factor inhibitor |
| 07/14/1998 | US5780647 2,4-Pentadienoic acid derivatives having retinoid-like biological activity |
| 07/14/1998 | US5780633 Enzyme inhibitor of testosterone 5-alpha-reductase |
| 07/14/1998 | US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom |
| 07/14/1998 | US5780611 Oligonucleotide which binds with double-stranded promoter region of human collagen gene to form triple helix complex |
| 07/14/1998 | US5780592 Transplant, antitumor |
| 07/14/1998 | US5780516 Material and methods for inhibiting bacterial cell wall biosynthesis |
| 07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
| 07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
| 07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
| 07/14/1998 | US5780501 Treatment method using anti-neurodegeneratively active 10-aminoaliphatyl-dibenz b,f!oxepines |
| 07/14/1998 | US5780500 Anti-neurodegeneratively active 10-aminoaliphatyl-dibenzi b,f! oxepines |
| 07/14/1998 | US5780487 S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
| 07/14/1998 | US5780486 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation or rheumatoid arthitis |
| 07/14/1998 | US5780485 Administering adrenergic blocking agent; side effect reduction; fda orange book listed patent for silodosin |
| 07/14/1998 | US5780477 Trisubstituted phenyl derivatives and processes for their preparation |
| 07/14/1998 | US5780474 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds |
| 07/14/1998 | US5780468 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
| 07/14/1998 | US5780455 Nonsettling acidic isotonic aqueous solution comprising sodium citrate, citric acid and sodium chloride |
| 07/14/1998 | US5780454 Boronic ester and acid compounds |
| 07/14/1998 | US5780449 Oligonucelotides; nucleotide sequences |
| 07/14/1998 | US5780445 Tocopheryl glycosides, their preparation, and their use as surfactants, as antioxidants and as the active substance preventing cell ageing in cosmetic or pharmaceutical preparations |
| 07/14/1998 | US5780436 Peptide compositions with growth factor-like activity |
| 07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |